BioXcel Therapeutics Overview
BioXcel Therapeutics Discounted Cash Flow
DCF Analysis for BTAI.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.08
Current Fair Value
$-1.08
↓ 190.2% Downside
Overvalued by 190.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison